BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: September 2024

1 post
CEL-SCI Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

Biotech NewsCEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

  • BioTech Health X
  • September 16, 2024
CEL-SCI Corporation (NYSE American: CVM) has announced new breakthrough data from its Phase 3 trial of Multikine®, an…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Wall Street Forgot About Teladoc (TDOC)—Here’s Why That Could Be a Huge Mistake
  • Cidara Therapeutics (CDTX) Surges After Breakthrough Flu Trial—Is This the Future of Seasonal Protection?
  • Cullgen Merger Could Make Pulmatrix (PULM) a Biotech Dark Horse
  • Capricor (CAPR) Emerges as a Top Buyout Target After Breakthrough Duchenne Data
  • CorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 23, 2025
    Wall Street Forgot About Teladoc (TDOC)—Here’s Why That Could Be a Huge Mistake
    • June 23, 2025
    Cidara Therapeutics (CDTX) Surges After Breakthrough Flu Trial—Is This the Future of Seasonal Protection?
    • June 23, 2025
    Cullgen Merger Could Make Pulmatrix (PULM) a Biotech Dark Horse
    • June 23, 2025
    Capricor (CAPR) Emerges as a Top Buyout Target After Breakthrough Duchenne Data
    • June 22, 2025
    CorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?
Recent Posts
  • Scinai (SCNI) Jumps 29%—Biotech Investors Are Betting on Scinai’s Dual-Revenue Model
    • June 22, 2025
  • Protagenic (PTIX) Explodes 300% After Merger With Phytanix—Is This the Next Biotech Breakout?
    • June 22, 2025
  • Windtree Therapeutics (WINT)’s Big Comeback: Will it be the Next Biotech Superstar?
    • June 22, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (207)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top